The redundancy of natural product biosynthesis in microbes poses a practical challenge for discovering new antimicrobial compounds from bacteria. The recent application of clustered regularly interspaced short palindromic repeats (CRISPR) technology by Culp et al. to inactivate the production of abundant antibiotics generates a metabolic clean slate for the detection and/or isolation of new and less plentiful antibiotics activated in mutant strains.
Keywords: CRISPR/Cas9; actinomycetes; antibiotic resistance; antibiotics; natural products.
Copyright © 2019 Elsevier Ltd. All rights reserved.